Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.6300
-0.0400 (-5.97%)
At close: Feb 4, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 86.22 million as of February 5, 2026. Its market cap has increased by 86.39% in one year.
Market Cap
86.22M
Enterprise Value
79.76M
Revenue
845.17K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.63
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 86.22M, an increase of 235.50%. That is a compound annual growth rate of 63.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 86.22M | 4.13% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 213.96M |
| EMVision Medical Devices | 168.22M |
| SomnoMed | 141.99M |
| Compumedics | 76.91M |
| Micro-X | 62.44M |
| CleanSpace Holdings | 51.34M |
| Nova Eye Medical | 49.84M |
| HeraMED | 46.94M |